6505--Prednisolone 1% Ophthalmic Solution
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79726R0037
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs (VA), through its NAC Pharmaceuticals office, has issued an active solicitation for the supply of Prednisolone 1% Ophthalmic Solution. This procurement, identified by solicitation number 36E79726R0037, seeks to secure pharmaceutical manufacturing services under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing. The associated Product Service Code is 6505, indicating a focus on drugs and biologicals.
The primary objective of this solicitation is to ensure a reliable supply of Prednisolone 1% Ophthalmic Solution, a critical medication used in the treatment of various ocular conditions for veterans under VA care. The scope of the procurement encompasses the manufacturing and delivery of this ophthalmic solution, adhering to stringent pharmaceutical standards to meet the needs of VA medical facilities nationwide. The intended outcome is to maintain continuity of care and support the health and well-being of veterans by providing high-quality, effective ophthalmic medication.
Key requirements for prospective contractors include demonstrated capability in pharmaceutical preparation manufacturing, specifically in producing ophthalmic solutions. Contractors must comply with all applicable federal regulations and quality assurance standards relevant to pharmaceutical products. The expected deliverables are units of Prednisolone 1% Ophthalmic Solution, manufactured, packaged, and delivered in accordance with VA specifications.
The contracting entity for this opportunity is NAC Pharmaceuticals, a federal office within the Department of Veterans Affairs. The solicitation is managed by Michael J. Olszewski, who serves as the primary point of contact and can be reached via email at [email protected] for further inquiries or clarifications.
This procurement is classified as a solicitation, and interested parties should note the response deadline of October 14, 2026, at 19:10. The notice remains active and is accessible through the SAM.gov portal, with additional details and attachments available at https://sam.gov/opp/1d0a91a5d520424ab19ecfa35b34bd89/view.
Contractors considering this opportunity should evaluate their capacity to consistently manufacture and supply Prednisolone 1% Ophthalmic Solution in compliance with VA requirements. The solicitation does not specify set-aside requirements or special considerations; therefore, all qualified manufacturers are encouraged to review the attached documentation and respond accordingly.
This procurement represents a stable, ongoing need for pharmaceutical manufacturing services within the VA system, offering contractors the opportunity to support veteran healthcare through the provision of essential ophthalmic medications.